1. Home
  2. HRMY vs AMPX Comparison

HRMY vs AMPX Comparison

Compare HRMY & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$27.73

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Amprius Technologies Inc.

AMPX

Amprius Technologies Inc.

N/A

Current Price

$18.27

Market Cap

1.5B

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
HRMY
AMPX
Founded
2017
2008
Country
United States
United States
Employees
N/A
108
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
AMPX
Price
$27.73
$18.27
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$46.70
$19.43
AVG Volume (30 Days)
1.1M
8.1M
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.87
$70.54
Revenue Next Year
$12.49
$73.64
P/E Ratio
$10.62
N/A
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$1.80
52 Week High
$40.87
$19.40

Technical Indicators

Market Signals
Indicator
HRMY
AMPX
Relative Strength Index (RSI) 30.66 74.03
Support Level $27.66 $10.00
Resistance Level $38.91 N/A
Average True Range (ATR) 1.25 1.20
MACD 0.08 0.80
Stochastic Oscillator 54.02 87.58

Price Performance

Historical Comparison
HRMY
AMPX

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

Share on Social Networks: